Synvisc-One has started to cement its place in the treatment protocol for osteoarthritis of knee amongst the orthopaedicians. Manufactured and marketed by Genzyme, Synvisc-One is the only US FDA approved single injection regimen that provides up to six months of relief from osteoarthritic (OA) knee pain.
The details can be read here.
No comments:
Post a Comment